Kongsberg Stock And The Defence Spending Surge

I keep coming back to a number that does not behave like a normal industrial statistic. NKr157 billion. That is the order backlog a Norwegian defence group was carrying into this phase of the spending cycle, roughly £12.4 billion, and the person running the company said he had not seen demand like it in a decade in the job. If you invest in listed manufacturers, you know the difference between a hopeful slide and a pile of signed work. One is a story. The other is a queue. Kongsberg stock is, at heart, a bet on how long that queue lasts, and whether the factories can chew through it without the margin falling over.

Perhaps the most interesting aspect is how ordinary the setup looks once you strip away the drama of geopolitics. Governments are buying kit they deferred for years. A specialist supplier already inside those programmes is getting paid to expand. The share is not cheap on next year’s earnings. It might look less stretched if the 2029 revenue ambition is even half serious. I have found that defence names reward patience more often than they reward clever timing, but only when the backlog is real and the balance sheet is not being used as a prop.

Why Kongsberg Stock Is Tied To A Spending Cycle That Finally Has Receipts

Talk of higher military budgets has been background noise for a while. What changed is the paperwork. At the Nato gathering in Ankara in July 2026, European allies and Canada were reported to have put more than $139 billion into core defence requirements over the prior year, alongside about $50 billion of fresh procurements and a pledge to widen manufacturing capacity. On top of that sat a commitment of $70 billion in equipment, training and support for Ukraine in 2026, with at least as much again pencilled in for 2027.

Those are political totals, not a purchase order with one company’s name on it. Still, they tell you the direction of travel. When treasuries move from speeches to appropriations, the firms that already own certified products tend to feel it first. Kongsberg Gruppen, listed in Oslo as KOG, sits in that pocket. Missiles that fit inside an F-35. Ground-based air defence sold with a large American partner. Sensors and vehicles that watch cables on the seabed. Counter-drone batteries for a country that shares a tense border with Russia.

I am not going to pretend any of this is elegant. Rearmament is a grim business. From a portfolio point of view, though, it is also one of the few industrial themes where the customer is not trying to negotiate the price down to nothing, because the alternative is an empty magazine. That does not make the equity a sure thing. It does make the demand side less flimsy than a consumer gadget cycle.

What The Group Actually Sells After The Split

In February 2026 the group spun its maritime arm out as a separately listed company, Kongsberg Maritime, so the remaining business could lean into three faster divisions. The mix, as described around that reshuffle, is straightforward enough to keep in your head.

• Defence Systems, the largest slice, about 47 percent of revenue, covering air defence, counter-drone work and related integrated systems.
• Missiles and Aerostructures, roughly 30 percent, the strike weapons and the structures that go with them.
• Discovery, about 23 percent, the sensing, subsea and monitoring side, including protection of critical underwater infrastructure.

The maritime exit matters more than a tidy org chart. Ship equipment and defence missiles do not deserve the same multiple, and they do not share the same bottlenecks. By peeling the slower maritime book away, management made the equity a cleaner expression of defence spending rather than a blended industrial conglomerate. Cleaner is not the same as safer. It just means the share price will now rise and fall with missiles, air defence and subsea security, not with offshore markets that have their own weather.

In my experience, spin-offs get over-analysed on day one and under-analysed six quarters later. The useful question is whether the remaining company reinvests the focus. Here, the early answer looks like yes. Capacity is being added. Two US businesses have been bought. The order book did not shrink when the ships left the consolidation.

A Quarter That Showed The New Shape

Results for the three months to the end of June 2026 were the first without the maritime division. Revenue rose 31 percent against the same period in 2025, to NKr10.4 billion. Earnings before interest and tax climbed 48.9 percent to NKr1.67 billion. The Ebit margin moved up to 16.1 percent. Order intake in the quarter ran at 164 percent of that quarter’s revenue, which is a clumsy way of saying the queue got longer even as the factory billed more.

Margins expanding while sales jump is the combination you want in a ramp. It suggests pricing and mix are not being given away to fill the line. It also suggests operating leverage is starting to show, which is what happens when fixed engineering teams suddenly have more units to spread across. I would not annualise one quarter and call it a religion. Defence revenue is lumpy. A missile batch can land in March or in July and make a headline look clever. Still, a near-50 percent lift in Ebit is not noise.

A backlog that is several times annual sales is not a victory lap. It is a delivery problem wearing a nice suit.

That line is mine, and I mean it. Investors love a fat order book because it feels like locked-in growth. Plant managers love it less, because every krona of backlog is a promise about labour, components, test slots and export licences. Kongsberg is spending to keep those promises. Cash outflow in the second quarter was NKr3.7 billion, funding acquisitions, product work and capacity. You do not get a 2029 revenue target without writing cheques in 2026.

The American Bolt-Ons And Why They Are Not Side Projects

In June 2026 the group finished buying Zone 5 Technologies, a California firm described as a leader in affordable, mass-producible munitions, including long-range strike weapons and interceptors. Zone 5 already had US work, including a contract tied to the US Air Force’s AGM-188 FAMM, the Family of Affordable Mass Missiles. Fold that into an existing American footprint and you are no longer a European exporter hoping Washington picks up the phone. You are inside the procurement conversation.

September brought Sonatech, another California specialist, this time in underwater acoustics. The technology is meant to feed autonomous underwater vehicles. That sits naturally next to the Discovery division’s work on monitoring and protecting subsea infrastructure. Cables, pipelines and sensors have become strategic assets in a way that would have sounded abstract a decade ago. They do not sound abstract if you have watched a map of the North Sea lately.

Are these deals transformative on their own? Probably not next quarter. They are transformative in mix. Affordable mass munitions are a different product philosophy from exquisite, low-volume missiles. Acoustics for unmanned boats is a different rhythm from a multi-year air-defence battery. Together they widen the catalogue without dragging the company back into merchant shipping. I like that logic. I also know integration is where nice press lines go to die, so the next few sets of accounts need to show these units pulling their weight rather than sitting as goodwill.

Missiles That Fit Inside The Aircraft

In July the group won a $100 million contract from the US Air Force for stealth air-to-surface Joint Strike Missiles, the JSMs that can be carried internally in the F-35A. Deliveries run out toward 2030. Internal carriage is not a footnote. It is the whole point of a low-observable fighter. A weapon that has to hang on a pylon gives away part of what the jet paid for. A weapon that rides inside keeps the signature down. That is why selection by Australia, Canada, Germany, Japan and Norway matters beyond the Norwegian home market. It is a club of F-35 operators, not a courtesy list.

The Missiles and Aerostructures division was also awarded JSM contracts totalling NKr10.9 billion for Canada, Germany and the United States. Put the US Air Force deal next to that European and Canadian book and you see a weapon moving from national project to allied standard. Standards are sticky. Once squadrons train on a missile, write the tactics and stock the spares, switching costs are ugly. That is the bull case in one sentence, and it is a fair one, provided production can scale without a quality embarrassment.

New plants in Australia and the United States are meant to supplement the existing Norwegian missile factory. Management has pointed to those overseas sites becoming operational in late 2027, with full-rate production in 2028. They are therefore a 2029 story more than a 2026 story. Anyone modelling next year’s earnings off Australian output is early. Anyone ignoring them when thinking about the back half of the decade is late.

Air Defence, Drones And A Wall On The Eastern Flank

Defence Systems saw strong demand in the second quarter for air defence and counter-drone systems. An agreement with partner Raytheon opened the way for NASAMS deliveries to Kuwait. NASAMS is not a new acronym to anyone who follows ground-based air defence, and a Gulf customer is a reminder that this franchise is not only a European rearmament trade. It travels.

The contract that grabs me, though, is the one with Poland. In January 2026 a deal worth NKr16 billion was signed for counter-drone batteries, a layered anti-drone wall inside Poland’s East Shield effort. Cheap drones changed the economics of the battlefield. A missile that costs a fortune to knock down a hobby airframe is a bad trade if you have to do it all afternoon. Purpose-built counter-UAS batteries are the industrial answer, and Poland is buying them in size.

Could other European states copy that wall? They might. I would not underwrite the equity on a chain of copycat orders that have not been signed. I would treat the Polish book as proof that the product has a buyer with a real threat, and keep the follow-on countries as upside rather than as base case. That is the difference between investing and storytelling.

Discovery, meanwhile, picked up work that includes monitoring and protection of critical subsea infrastructure. It is the quiet third of the company, and quiet divisions get ignored until a cable is cut. If you want a hedge that is not pure kinetics, this is the piece. Sensors, autonomy, acoustics from the Sonatech deal. Less headline, more annuity, if the contracts renew.

The Backlog, Translated Into Plain Language

At the 2025 year-end the backlog stood at NKr157 billion. By the end of the second quarter of 2026 it was still cited at NKr157 billion, after a quarter in which intake ran well ahead of revenue. Coverage has been framed at about 3.6 times annual revenue. For a manufacturer, that is a long runway. It does not mean every krona converts at the same margin, and it does not mean none of it slips. Export approvals, customer funding and component lead times can all shove a delivery into the next year. Even so, a book that large is the opposite of a company hunting for work.

Think of it as a restaurant with tables booked through next winter. You still have to cook. You can still have a bad Saturday. But you are not standing at the door hoping someone walks in. Kongsberg is in that position, and it is spending to add kitchens in Australia, the United States and, for subsea technology, at home in Norway.

I would tape that table above the broker note. The targets are ambitions, not covenants. The quarterly prints are history. The gap between them is the investment.

Cash, Debt And The Odd Luxury Of A Net Cash Lean

At the end of the second quarter, cash and equivalents were NKr4.9 billion against loans and lease liabilities of NKr2.1 billion. That is a strong balance sheet for a company writing expansion cheques. Market value around the recent price of NKr312.7 was about NKr275 billion. Forward dividend yield sat near 0.7 percent. Nobody is buying this for income. The yield is a rounding error next to the growth pitch, and that is fine as long as you know which seat you are in.

A one-year price target circulated near NKr396.4. Targets are opinions with a spreadsheet attached. I treat them as a map of consensus mood, not as a destination. What I care about more is whether net cash survives the factory build. A defence ramp that tips into heavy net debt just as a budget cycle pauses is how good franchises become mediocre shares. So far the balance sheet is not the problem.

What Analysts Are Sketching For 2027

Street estimates have pointed to 2027 revenue of about NKr64.2 billion, a 49 percent step up from 2026. Earnings per share have been sketched at NKr11.2, up about 52 percent. On a share price of NKr312.7, that implies a 2027 price-to-earnings ratio around 27.9. Growth stocks wear multiples like that when the runway looks long. They look ridiculous when the runway was a mirage.

Here is the arithmetic that makes the bulls sit up. If the group hits the 2029 revenue target of NKr100 billion, and earnings per share rise only in line with sales, the same share price would imply a 2029 multiple nearer 18.3. That is not a promise. It is a sensitivity. Proportional earnings are a generous assumption if mix worsens, and a modest one if operating leverage keeps doing what it did in the June quarter. I would rather underwrite something between those poles than either extreme.

The contributors lined up under that revenue path are not mysterious. Zone 5 and Sonatech. Missile plants in Australia and the United States reaching rate in 2028. A Norwegian subsea build-out. The Polish counter-drone contract and whatever air-defence follow-ons actually get signed. JSM batches for allies who have already selected the weapon. None of that requires a science-fiction scenario. It requires execution and budgets that do not get clawed back.

Capacity Is The Constraint, Not The Slogan

European politicians have spent two years saying industry must expand. Industry has spent two years saying it will, once the orders are firm and the permits arrive. Kongsberg is one of the names actually pouring concrete, or at least committing to plants with dates on them. Late 2027 for operational status in Australia and the US. Full rate in 2028. A revenue marker of NKr100 billion by 2029, which would be about 2.3 times projected 2026 sales, and NKr150 billion by 2033.

More than trebling turnover in seven years is a bold sentence. I have watched industrial targets like that miss because hiring skilled testers takes longer than the slide assumed, or because a single exported subsystem becomes the bottleneck. I have also watched them land when the customer is a state and the product is already qualified. Defence is closer to the second pattern, with a nasty twist: export control. A factory in the United States helps with American orders. It does not magically clear every third-country transfer.

Directors having skin in the game is a small comfort, not a strategy. The chief executive was reported to hold 250,000 shares, with two executive vice-presidents holding 230,000 between them. That is alignment, not a moat. Still, I would rather see it than a leadership team paid entirely in cash while asking shareholders to fund a multi-year build.

The Demand Backdrop, Without The Rally Rhetoric

It is worth sitting with the Ankara figures again, because they frame every European contractor, not just this one. More than $139 billion into core requirements from European allies and Canada over a year. About $50 billion of new procurements. A capacity pledge. Then $70 billion toward Ukraine for 2026, and a floor of a similar sum for 2027. Even if half of that is wages, fuel and legacy platforms, the residual flowing to missiles, air defence, sensors and counter-drone kits is large next to Kongsberg’s current sales base.

The company is not the only mouth at that trough. American primes, European peers, and a swarm of smaller drone specialists are all pitching. Kongsberg’s edge, as I read it, is specificity. A missile already selected by several F-35 nations. An air-defence system with an entrenched American partner and a new Gulf delivery path. A counter-drone award on the eastern flank. A subsea book that matches a threat people can point at on a chart. Specific beats thematic, most years.

• US exposure through JSM, Zone 5 and a domestic missile plant still ramping.
• Asian and Pacific exposure through Australian production and existing JSM selection.
• European exposure through Germany, Poland, Norway and the wider air-defence refresh.
• A Gulf datapoint via NASAMS to Kuwait, so the map is not only the North Atlantic.

Geographic spread will not save a bad product. It does reduce the chance that one parliament’s budget fight zeroes out the year. That is the practical version of diversification, and it is worth more here than a pie chart in a fund factsheet.

Where The Bull Case Can Still Break

I get uneasy when a defence pitch is written as if politics only moves one way. Budgets can be delayed. Coalition governments can trade a missile line for a tax cut. A ceasefire headline can knock the whole sector for a month even if the multi-year contracts stay in force. Kongsberg stock will feel those air pockets. A 28 times multiple on 2027 earnings does not leave much room for a dull year.

Execution risk is the grown-up risk. Plants slip. Acquired software does not talk to legacy test gear. A mass-producible munition turns out to be harder to mass-produce than the pitch deck said. Currency is another quiet one. Reporting in kroner while selling in dollars and euros means translation noise, sometimes in your favour, sometimes not. And competition in counter-drone systems is ferocious, because the barrier to a prototype is low even if the barrier to a certified battery is high.

There is also concentration in programmes. JSM is a jewel. If a customer slows induction, or if a rival weapon wins the next tranche, the 2029 bridge loses a plank. I do not see that as the base case given the selection list, but it belongs on the page. So does the simple fact that a backlog can be renegotiated. States do it. Rarely, and loudly, but they do it.

A rough owner's checklist:
  Backlog cover still near multi-year?
  Ebit margin holding around the mid-teens?
  Overseas plants on the late-2027 clock?
  Net cash not flipping into structural debt?
  New US units showing revenue, not just headlines?

If three of those five go the wrong way at once, the multiple will do the damage before the factories do. That is how growth shares work. The business can be fine and the entry price can still be wrong.

How I Would Frame A Position, Not A Slogan

This is not a dividend compounder and it is not a deep value scrap. It is a growth industrial tied to state budgets, with a backlog that already does a lot of the arguing. At NKr312.7, you are paying up for 2027 and hoping 2029 makes the multiple look ordinary. The one-year consensus target near NKr396 implies further upside if estimates hold. It also implies that a lot of good news is already in the conversation.

If I were building a watchlist rather than a victory speech, I would want the next two quarters to show three boring things. Order intake that does not collapse after a strong comparison. A margin that stays in the neighbourhood of 16 percent rather than giving back the June gain. And some evidence that Zone 5 and Sonatech are being integrated without a special charge every other month. Boring is good. Defence ramps that stay boring tend to be the ones that hit the out-year numbers.

Position size matters more than usual because the theme is crowded. Plenty of portfolios already own a missile prime, a European air-defence name, or a broad defence basket. Adding Kongsberg stock on top is a concentration in the same macro bet, even if the product list differs. I would size it as a satellite unless the rest of the book is light on the sector. Correlation shows up on the red days, not in the brochure.

A Longer Look At The Product Logic

Strip the ticker off for a minute and the industrial logic is almost old-fashioned. Qualify a weapon. Win a handful of reference customers. Tool a factory. Then sell the same qualified article to allies who do not want to pay for a fresh development programme. JSM follows that path. Internal carriage on the F-35A is the qualification that matters. Norway, Australia, Canada, Germany, Japan and the US Air Force contract are the references. The Australian and American plants are the tooling. If that sequence completes, the 2030 delivery window stops being a press line and becomes a production schedule.

NASAMS is the older sibling of that story. Partnered with Raytheon, already fielded, now extending to Kuwait. Older franchises do not excite momentum accounts. They pay for the lights while the new plants come up. I would not want a Kongsberg investment case that relied only on the new stuff. The installed air-defence base is what makes the counter-drone add-on believable. Customers who already run your battery are the ones who will take a layered anti-drone module without a five-year trial.

Then there is the affordable-mass angle from Zone 5. High-end missiles and cheap mass weapons are not substitutes. A force needs both, which is an awkward truth for treasuries and a useful truth for a supplier that can offer each. The FAMM-related work is a foothold in the American argument about magazine depth. Magazine depth is the phrase that replaced precision as the scarce resource, at least in the briefings I keep seeing summarised. If that shift sticks, a Californian unit that knows how to build volume sits in the right argument.

Sonatech is the least cinematic of the recent moves, and maybe the one that ages best. Underwater acoustics do not trend on social feeds. They do decide whether an autonomous vehicle can hear what it needs to hear near a cable route. Discovery’s contract for monitoring critical subsea infrastructure is the commercial twin of that technology. Put them together and you have a small stack: sensor, vehicle, service. Stacks renew. One-off missile batches do not, or not in the same way.

Valuation, In Words Rather Than In A Shout

A 27.9 times multiple on projected 2027 earnings is a growth rating. Full stop. You can dress it up with the backlog, and you should, because 3.6 years of revenue in the book is not what you see at a cyclical truck maker at the top of a freight boom. You still have to believe earnings get to NKr11.2 and then keep climbing. If 2027 lands closer to flat, the multiple will not wait around to be kind.

The 18-ish times sketch for 2029, assuming earnings merely pace revenue up to NKr100 billion, is the number that makes long-horizon holders relax. I would write it in pencil. Revenue targets at defence firms have a habit of being right in direction and late in timing. A plant that opens in early 2028 instead of late 2027 does not kill the franchise. It does move the year in which the multiple compresses for the right reason, which is higher earnings, rather than the wrong reason, which is a derating.

Yield at 0.7 percent tells you capital is staying inside the business. Good, given the build. Frustrating if you wanted a payer. There is no need to force this share into an income sleeve. It will disappoint you there, and the disappointment will be your fault.

Pay a growth multiple only for growth you can point at in a backlog, a plant date, or a signed allied selection. Everything else is atmosphere.

A portfolio rule I keep failing to ignore

On that rule, Kongsberg clears the first screen. The backlog is quantified. The plant dates are public. The JSM selections are a list, not a vibe. The second screen is price, and that one is closer. You are not being handed a distress valuation. You are being asked to underwrite a ramp that management has already started funding.

What Could Surprise On The Upside

Follow-on counter-drone orders if other European states copy Poland’s layered wall. Further JSM tranches as more F-35 squadrons move from delivery to weapons integration. A faster contribution from Zone 5 if US affordable-mass programmes accelerate. Subsea protection work that turns from project revenue into a multi-year service. Any one of those would make the NKr100 billion marker look less like a stretch. All of them together would make the 2033 figure of NKr150 billion look like a plan rather than a poster.

I would still refuse to add them up and call it destiny. Defence surprises cut both ways. A single large award can drop in a quarter and flatter intake. A single protest or licence delay can shove it out. The honest upside is capacity plus repeat customers, not a lottery ticket on the next summit communique.

What A Dull Bear Case Looks Like

Not a collapse. A pause. European budgets grow more slowly after the first catch-up wave. The Australian line opens late. Zone 5 stays a respectable niche rather than a second engine. The share, priced for a 50 percent revenue step into 2027, spends a year digesting. Earnings still rise. The multiple falls toward the high teens earlier than bulls hoped, and the total return is ordinary. That outcome would not make the company a mistake. It would make the entry point a bit eager.

The harsher bear case needs a programme stumble or a political reversal big enough to freeze export licences. I rate that as possible and not central. The milder bear case is the one that actually hits most growth industrials: time. Time is expensive when you paid 28 times.

Reading The Next Update Without Getting Lost

When the next set of figures lands, skip the adjective in the first paragraph and look for four lines. Revenue versus the NKr10.4 billion quarter, so you can see if 31 percent growth was a spike. Ebit margin versus 16.1 percent. Order intake versus revenue, because a book that stops growing is a different company. And cash, because NKr4.9 billion against NKr2.1 billion of loans and leases is the cushion under the build. If those four hold their shape, the long targets deserve to stay on the page.

I would also listen for language around the Australian and US sites. “On track for late 2027” is the phrase you want. “Rephased” is the phrase that means your 2029 bridge just got longer. Management teams rarely use the second word until they have to. The absence of a date is sometimes the tell.

Division commentary is worth more than the group total. Defence Systems should keep talking about air defence and counter-drone. Missiles should keep talking about JSM batches and, in time, Zone 5 volume. Discovery should keep talking about subsea infrastructure rather than drifting into generic digital jargon. If the words go vague, the orders may be going vague too.

Putting It Next To A Normal Industrial

Compare this, mentally, with a capital-goods name that sells to factories. That company lives on customer capex cycles, which turn fast when rates rise. Kongsberg lives on multi-year state programmes, which turn slowly and then all at once when a threat feels close. The multiple is higher here because the visibility is higher. The political risk is also higher, because your customer wears a flag. Both can be true. The job is not to pretend the flag risk is zero. The job is to decide whether 3.6 years of backlog and a net cash lean are enough payment for it.

For me, they are enough to keep the name on a serious list, not enough to ignore the price. I have found that the shares which hurt in this sector are the ones bought after a summit, at the high, with the plant still a drawing. Kongsberg is past the drawing. It is not past the price debate.

A Plain Summary You Can Argue With

Kongsberg, after the maritime spin-off, is a defence and sensing group with three divisions, a NKr157 billion backlog, and a June quarter that grew revenue 31 percent and Ebit almost 50 percent. It is adding US munitions and acoustics through Zone 5 and Sonatech. It has JSM work for the US Air Force and allied selections that include Australia, Canada, Germany, Japan and Norway. It has NASAMS moving toward Kuwait with Raytheon, and a NKr16 billion Polish counter-drone award. Plants in Australia and the US are aimed at late 2027, full rate in 2028, feeding a 2029 revenue hope of NKr100 billion and a 2033 hope of NKr150 billion.

The balance sheet can fund a chunk of that without looking stretched. The dividend will not move the needle. The 2027 earnings multiple, near 28 times at NKr312.7, assumes the ramp continues. If earnings only keep pace with a NKr100 billion revenue year, that same price looks closer to 18 times. Directors own stock. Demand, for once, is not the slide. Delivery is.

Would I call it the only way to own the spending cycle? No. Would I call the backlog a mirage? Also no. Somewhere between those two refusals is a share that deserves a proper model, a sized position, and a bit of scepticism about any sentence that ends in 2033. The queue is real. The cooking still has to happen.